REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cande S.R.O. (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Direct Selling Establishments | Advertising Agencies | All Other Schools and Instruction
Full name: Cande S.R.O. Profile Updated: July 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

CANDE s.r.o is a pharmaceutical company that operates in Central Europe, specifically in Slovakia and the Czech Republic. Their portfolio includes generic prescription drugs, free-selling drugs, and medical devices, all produced under the CANDE corporate brand and approved by the State Institute for Drug Control. Their goal is to bring safe and effective products to the market at a reasonable price.

Headquarters
E.Bellusa, 6752/4
Piestany; Trnavsky; Postal Code: 92101

Contact Details: Purchase the Cande S.R.O. report to view the information.

Website: https://cande.sk/

Basic Information
Total Employees:
Purchase the Cande S.R.O. report to view the information.
Registered Capital:
Purchase the Cande S.R.O. report to view the information.
Financial Auditors:
Purchase the Cande S.R.O. report to view the information.
Incorporation Date:
May 22, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Cande S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.45%▲
Total operating revenue
12.86%▲
Operating profit (EBIT)
31.06%▲
EBITDA
29.43%▲
Net Profit (Loss) for the Period
33.94%▲
Total assets
57.95%▲
Total equity
38.25%▲
Operating Profit Margin (ROS)
3.32%▲
Net Profit Margin
2.92%▲
Return on Equity (ROE)
-1.14%▼
Debt to Equity Ratio
-1.37%▼
Quick Ratio
-0.73%▼
Cash Ratio
-0.36%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo